AbCellera (ABCL), Everest to Co-Develop New Antibody Therapies Posted byZacks Equity Research September 23, 2021 Leave a comment on AbCellera (ABCL), Everest to Co-Develop New Antibody Therapies AbCellera (ABCL) partners with China-based Everest Medicines to expand the latter???s pipeline across multiple indications.